Caesalpinia bonduc L. (Fabaceae) is a medicinal plant predominantly distributed in the tropical and subtropical regions of Asia and the Caribbean. It is locally known as Nata Karanja (Hindi) in India and Kuburu in Sri Lanka, and possesses a lot of applications in folk medicines. For instance, its seed and bark extracts have been used as antihelmintic, anticancer, antimalarial, hypoglycemic, anti-inflammatory, antimicrobial, antirheumatic and antipyretic agents.1,2) Previous phytochemical investigations on C. bonduc and some other members of the family Fabaceae have resulted in the isolation of several cassane and norcassane furanoditerpenes.3-6) Some of these compounds were reported to exhibit inhibitory activity against interleukin-1 production 4) and growth inhibitory activity against malaria-causing Plasmodium falciparum.
5)The glutathione S-transferase (GST) system is a primary cellular mechanism protecting against cytotoxic and genotoxic stress. GST isoenzymes are phase II detoxification enzymes that catalyze the conjugation of cytotoxic agents to glutathione producing a less reactive, water-soluble chemical species.7) Physiological activities of these enzymes have been implicated in development of resistances by cancer cells and parasites towards chemotherapeutic agents and the body immune system, respectively. 8,9) Inhibition of GST has been proposed to improve prognosis in patients during cancer chemotherapy, and can be applied as adjuvant in antiparasitic chemotherapy and as antiparasitic drugs.10,11) In our continuing effort to discover bioactive natural products from plant and marine sources, we discovered that the crude ethanolic extract of C. bonduc exhibited concentration-dependent GST inhibitory activity with an IC 50 value of 83 mg/ml. Based on this activity, we performed bioassay-guided fractionations on this crude extract to isolate natural products exhibiting GST inhibitory activity. Consequently, we have successfully isolated a new sterol, 17-hydroxy-campesta-4,6-dien-3-one (1) as well as four known compounds, 13,14-seco-stigmasta-5,14-dien-3a-ol (2), 13,14-seco-stigmasta-9(11),14-dien-3a-ol (3), caesaldekarin J (4) and pipataline (5) as GST inhibitors. Spectroscopic methods were used to establish the structures of these new and known compounds. This paper describes the isolation and structure elucidation of these compounds as well as their GST inhibitory activity data. Three derivatives of compounds 2 and 3 were prepared to investigate the effects of the C-3 hydroxyl group and the C-5/C-6 double bond in 13,14-seco-steroids on GST inhibition. Inhibition of GST by compounds 1-5 and derivatives of 2 and 3 (2a, 3a, b) was compared with activity of sodium taurocholate, a standard steroidal GST inhibitor under similar assay conditions. This indicated that the newly isolated compounds have more or less same activity as that of the standard inhibitor. Nearly half a dozen of 13,14-seco-steroids have been reported in the literature, [12][13][14] and no comments on their biosynthetic origin have been p...